Sponsor pipeline

Nanjing First Hospital, Nanjing Medical University clinical trial pipeline

Get alerts when Nanjing First Hospital, Nanjing Medical University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-29 NCT07847515 Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug… Not Yet Recruiting
2026-09-25 NCT07841223 Transoral Nasal Cannula Oxygen Therapy for Mouth-Breathing Patients in the Postanesthesia… Recruiting
2026-09-21 NCT07832175 AI-CCTA for Predicting Cardiovascular Events in CAD Active, Not Recruiting

Active trials by phase

Early Phase 1
1
Phase 2
1
Phase 3
3
Phase 4
8
Not charted: 74 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 22

Heart Disease (22) · Coronary Artery Disease (17) · Stroke (7) · Diabetes (5) · Heart Failure (4) · Lung Cancer (3) · Type 2 Diabetes (3) · Depression (2) · Head & Neck Cancer (2) · Hypertension (2)

Get alerts when Nanjing First Hospital, Nanjing Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free